CN108741103A - A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof - Google Patents
A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof Download PDFInfo
- Publication number
- CN108741103A CN108741103A CN201810622097.8A CN201810622097A CN108741103A CN 108741103 A CN108741103 A CN 108741103A CN 201810622097 A CN201810622097 A CN 201810622097A CN 108741103 A CN108741103 A CN 108741103A
- Authority
- CN
- China
- Prior art keywords
- oil
- mixed
- small peptide
- acid
- flu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 46
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 44
- 230000036039 immunity Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003921 oil Substances 0.000 claims abstract description 35
- 235000019198 oils Nutrition 0.000 claims abstract description 35
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- 239000008158 vegetable oil Substances 0.000 claims abstract description 17
- 235000014121 butter Nutrition 0.000 claims abstract description 15
- 235000019197 fats Nutrition 0.000 claims abstract description 15
- 150000001413 amino acids Chemical class 0.000 claims abstract description 14
- 239000005018 casein Substances 0.000 claims abstract description 12
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000021240 caseins Nutrition 0.000 claims abstract description 12
- 230000007062 hydrolysis Effects 0.000 claims abstract description 12
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 7
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- 235000010755 mineral Nutrition 0.000 claims description 17
- 239000011707 mineral Substances 0.000 claims description 17
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 16
- 229940088594 vitamin Drugs 0.000 claims description 16
- 239000011782 vitamin Substances 0.000 claims description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 15
- 108091005804 Peptidases Proteins 0.000 claims description 15
- 239000004365 Protease Substances 0.000 claims description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 15
- 235000019419 proteases Nutrition 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 239000011734 sodium Substances 0.000 claims description 15
- 229910052708 sodium Inorganic materials 0.000 claims description 15
- 238000001694 spray drying Methods 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 230000002779 inactivation Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 claims description 9
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 150000005691 triesters Chemical class 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 235000021342 arachidonic acid Nutrition 0.000 claims description 8
- 229940114079 arachidonic acid Drugs 0.000 claims description 8
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- 239000006188 syrup Substances 0.000 claims description 8
- 235000020357 syrup Nutrition 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 235000021119 whey protein Nutrition 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 239000004519 grease Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 229960000984 tocofersolan Drugs 0.000 claims description 5
- 239000002076 α-tocopherol Substances 0.000 claims description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 4
- 235000019743 Choline chloride Nutrition 0.000 claims description 4
- 235000000638 D-biotin Nutrition 0.000 claims description 4
- 239000011665 D-biotin Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 235000019482 Palm oil Nutrition 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 229960003178 choline chloride Drugs 0.000 claims description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 4
- -1 compound Vitamin Chemical class 0.000 claims description 4
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 4
- 239000011666 cyanocobalamin Substances 0.000 claims description 4
- 229960002104 cyanocobalamin Drugs 0.000 claims description 4
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 239000011790 ferrous sulphate Substances 0.000 claims description 4
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 4
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 4
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 229940099596 manganese sulfate Drugs 0.000 claims description 4
- 239000011702 manganese sulphate Substances 0.000 claims description 4
- 235000007079 manganese sulphate Nutrition 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 239000002540 palm oil Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 4
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 4
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 4
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 4
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 4
- 229960001763 zinc sulfate Drugs 0.000 claims description 4
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 229940071162 caseinate Drugs 0.000 claims description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 239000001334 starch sodium octenyl succinate Substances 0.000 claims description 3
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 229930192627 Naphthoquinone Natural products 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019742 Vitamins premix Nutrition 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 150000002791 naphthoquinones Chemical class 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229960003975 potassium Drugs 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 238000005660 chlorination reaction Methods 0.000 claims 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 4
- 229930195729 fatty acid Natural products 0.000 abstract description 4
- 239000000194 fatty acid Substances 0.000 abstract description 4
- 239000008101 lactose Substances 0.000 abstract description 4
- 102000004407 Lactalbumin Human genes 0.000 abstract description 3
- 108090000942 Lactalbumin Proteins 0.000 abstract description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 3
- 230000001079 digestive effect Effects 0.000 abstract description 3
- 150000004665 fatty acids Chemical class 0.000 abstract description 3
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 229960004488 linolenic acid Drugs 0.000 abstract description 3
- 239000002773 nucleotide Substances 0.000 abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 abstract description 3
- 230000008855 peristalsis Effects 0.000 abstract description 3
- 230000008717 functional decline Effects 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 239000011573 trace mineral Substances 0.000 abstract description 2
- 235000013619 trace mineral Nutrition 0.000 abstract description 2
- 238000010237 hybrid technique Methods 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000005862 Whey Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000020610 powder formula Nutrition 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008115 glucose syrup 50% Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000009868 osmotic diarrhea Diseases 0.000 description 1
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides a kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof, it is prepared with dry and wet hybrid technique, wherein lactalbumin and casein are immune small peptide and amino acid after hydrolysis, small peptide absorbs quick, and energy 100% is absorbed by the body, and is suitble to the slow digestive function decline crowd of gastrointestinal peristalsis during flu；Also addition long-chain fat DHA and ARA, middle carbochain fat MCT and short-chain fat butter oil anhydrous butter oil, the fatty acid profile equilibrium other than mixed vegetable oil, and the addition of short-chain fat enhances palatability；The present invention contains the daily required multivitamin of 0-6 month babies and trace element and linoleic acid, alpha-linolenic acid aliphatic acid, DHA, ARA, nucleotide etc., content meets national standard, and it is not added with lactose, infiltration is forced down, and reduces baby's gastrointestinal tract burden, flu phase 0-6 month infantile health demand can be more met compared to regular convention formula powder.
Description
Technical field
The invention belongs to dairy products technical fields, a kind of flu phase small peptide formula powder more particularly to strengthen immunity and
Preparation method.
Background technology
Flu is the upper respiratory disease caused by virus, mixed infection or allergy, is mainly shown as fever, dislikes
The symptoms such as cold, headache, nasal congestion, sneezing, cough, weak, DOMS, are a kind of self-healing property diseases.The annual sense of adult
2-3 times average, children then about 8-10 times are emitted, the 21% virgin annual flu of baby is up to 12 times.75% patient has fever disease when flu
Shape, the metabolism of adstante febre body substance can enhance, and body temperature often increases 1 DEG C, and basal metabolic rate can improve 13%, cold, fever digestive juice
Secretion is reduced, and digestive enzyme activity reduces, and gastrointestinal peristalsis is slow.
0-6 months baby's flu are exactly the cold disease that people suffers from 0-6 month cradles, since a 0-6 month babies support
Anti- ability is low to be caused, and complication is easy to cause.0-6 months baby's flu and the flu of adult are different, it is mainly 0-6 months
For baby since the resistance of body is very weak, the probability of virus infection is relatively high for adult.Simultaneously as 0-6 months
The ability to bear of babies is weaker, and cold, fever causes gastrointestinal function to decline, and still uses breast-feeding or common at this time
Milk powder is fed, and can often cause carbohydrate to be accumulated in enteric cavity causes osmotic diarrhea to make protracted inflammation, continues breast milk or cow milk feeding
Often aggravate diarrhea and fever.Stop breast milk and lactase-containing comestibles intake, the small peptide formula powder for using strengthen immunity instead is most
Simple effective method.It takes the flu phase small peptide formula powder of short-term strengthen immunity is auxiliary to control 0-6 months baby's flu, disease can be made
Journey is obviously shortened.Infant is easy to restore normal diet and the state of an illness is without repeatedly, and tracing study infant growth and development is better.Therefore,
Illustrate the flu phase small peptide formula treated powder of strengthen immunity and most important, value of growing up to it to the control of new born youngster's diet
Obtain clinical application.
Invention content
In view of the foregoing deficiencies of prior art, the purpose of the present invention is to provide a kind of flu phases of strengthen immunity
Small peptide formula powder and preparation method thereof, a kind of flu phase small peptide formula powder formula powder of strengthen immunity mix work with dry and wet
Prepared by skill, wherein lactalbumin and casein are hydrolyzed to small peptide and amino acid after hydrolysis process, and small peptide absorbs quickly, and energy
100% is absorbed by the body, and is suitble to the slow digestive function decline crowd of gastrointestinal peristalsis during flu.Also add other than mixed vegetable oil
Chain fatty DHA and ARA, middle carbochain fat MCT and short-chain fat butter oil anhydrous butter oil are lengthened, fatty acid profile is balanced, and short
The addition of chain fatty enhances palatability.
In order to achieve the above objects and other related objects, the present invention provides a kind of flu phase small peptide formula of strengthen immunity
Powder, it is characterised in that the flu phase small peptide formula powder of the strengthen immunity includes that following raw material is made：Concentrated whey protein powder
3%-15%, casein sodium 2%-10%, glucose syrup 40%-61%, mixed vegetable oil 10%-36%, docosahexaenoic acid grease
0.1%-0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.1%-0.5%, arachidonic acid oil 0.1%-0.5%, anhydrous butter oil 0.1%-0.5%；It is multiple
Vitamin 0.1%-0.6%, composite mineral matter 0.4%-2.2% are closed, the percentage is that flu phase small peptide is formulated powder raw material gross mass
Mass percent；The mixed vegetable oil includes following components：Soybean oil 1%-15%, palm oil 5%-21%, sunflower oil 4%-
15%, linseed oil 0.5%-5.0%, the percentage are the mass percent of mixed vegetable oil raw material gross mass.
Preferably, the composite mineral matter is 0-6 month baby's mineral substance premixes, by the material of following weight percent
Mixture forms：Calcium carbonate 21-36%, potassium chloride 21-32%, magnesium sulfate 15-30%, sodium citrate 11-22%, tricalcium phosphate 5-20%,
Ferrous sulfate 1.5-3.0%, zinc sulfate 0.78-1.18%, copper sulphate 0.086-0.166%, manganese sulfate 0.01-0.08%, potassium iodide
0.008-0.022%, sodium selenite 0.002-0.005%.
Preferably, the multi-vitamins are 0-6 month baby's vitamin premixs, by the material of following weight percent
Mixture forms：L-AA sodium 45-61%, choline chloride 15-31%, inositol 15-30%, niacinamide 1-5%, D-VB5 calcium 0.6-
2%, D-Biotin 0.1-1.0%, cyanocobalamin 0.1-0.8%, thiamine hydrochloride 0.1-0.6%, puridoxine hydrochloride 0.08-0.4%, core
Flavine 0.04-0.2%, folic acid 0.01-0.18%, dl- α-D-α-tocopherol acetates 6.0-7.5%, axerophtholum aceticum 1.5-3%, courage calcification
Alcohol 0.4-1.2%, phytondione 0.2-1.0%.
A kind of preparation method of the flu phase small peptide formula powder of strengthen immunity, it is characterised in that include the following steps：
It is prepared by base-material（Wet processing）：（1）It is prepared by water phase：Concentrated whey protein powder, casein sodium are dissolved in 36 DEG C -50 DEG C
Purified water in, be added compound protease be hydrolyzed, pH value 6.0-8.0, hydrolysis temperature be 36-55 DEG C, hydrolysis time 30-
120min is hydrolyzed to by the peptide or amino acid of 12 amino acid consisting of, and molecular weight is below 4000；Heat inactivation compound protein
Enzyme, inactivation temperature is 80 DEG C -98 DEG C, time 5min-15min, after being cooled to room temperature, glucose syrup is added, stabilizer high speed is cut
It cuts uniformly mixed, obtains feed liquid A；（2）It is prepared by oil phase：By mixed vegetable oil and Glycerin, mixed triester with caprylic acid capric acid, docosahexaenoic acid oil
After mixing, emulsifier 10-32min, emulsifying temperature 60-75 is added in fat, arachidonic acid oil, anhydrous butter oil
DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, composite mineral matter is added, by shear-mixed, kills
Material C is obtained after bacterium, spray drying, the spray drying also includes fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40
℃；
It is dry-mixed（Dry process）：（4）Multi-vitamins are uniformly mixed with material C to get product；
Or include the following steps：
It is prepared by base-material（Wet processing）：（1）It is prepared by water phase：Concentrated whey protein powder, casein sodium are dissolved in 36 DEG C -50 DEG C
Purified water in, be added compound protease be hydrolyzed, pH value 6.0-8.0, hydrolysis temperature be 36-55 DEG C, hydrolysis time 30-
120min is hydrolyzed to by the peptide or amino acid of 12 amino acid consisting of, and molecular weight is below 4000；Heat inactivation compound protein
Enzyme, inactivation temperature is 80 DEG C -98 DEG C, time 5min-15min, after being cooled to room temperature, glucose syrup is added, stabilizer high speed is cut
It cuts uniformly mixed, obtains feed liquid A；（2）It is prepared by oil phase：By mixed vegetable oil and Glycerin, mixed triester with caprylic acid capric acid, docosahexaenoic acid oil
After mixing, emulsifier 10-32min, emulsifying temperature 60-75 is added in fat, arachidonic acid oil, anhydrous butter oil
DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, is obtained after shear-mixed, sterilization, spray drying
Material C, the spray drying also include fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, composite mineral matter are uniformly mixed with material C to get product.
Preferably, the step（1）In compound protease include flavor protease, alkali protease, neutral proteinase,
Its additive amount is that addition enzyme-activity unit is 12100-15000U in every 100mL PURE WHEYs, na caseinate solution；It is described
Stabilizer be selected from 1.0%-2.5% potassium citrate, the percentage be flu phase small peptide be formulated powder raw material gross mass quality
Percentage.
Preferably, the step（2）In emulsifier be starch Sodium Octenyl Succinate 0.1%-1.5%, citric acid fat
Acid glyceride 0.0%-1.5%, single diglycerol acid aliphatic ester 0.0%-1.5%, the percentage are that flu phase small peptide formula powder is former
Expect the mass percent of gross mass.
Preferably, the step（3）In sterilization conditions be 68 DEG C -70 DEG C of temperature, time 21-40min；It is spray-dried item
Part is 160 DEG C -190 DEG C of inlet air temperature, 80 DEG C -95 DEG C of temperature of outgoing air.
Preferably, the step（3）In spray drying be selected from fluidized bed drying, fluidized bed drying temperature be 30 DEG C -40
℃
As described above, a kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof of the present invention, has with following
Beneficial effect：First, to based on humanized amino acid spectrum lactalbumin and casein hydrolyzed three times, be hydrolyzed to small peptide and ammonia
Base acid, small peptide absorb quickly, and energy 100% is utilized by human body, have easy absorption effect easy to digest；Second, Fatty acids composition is equal
Weighing apparatus, in addition to adding vegetable oil, also added DHA and ARA, middle carbochain fat MCT and short chain butter oil butter oil（Anhydrous milk
Oil）Addition can enhance agreeable to the taste sense；Third, being not added with lactose, 0-6 months baby's gastrointestinal tract burdens are reduced, prevent lactose not
The generation of tolerance, product disclosure satisfy that dissolubility is good, and shelf stable is not oxidizable needed for 0-6 month infants growth and developments.
Its carbohydrate content is relatively low, is easy to respiratory symptom during alleviation flu.
Specific implementation mode
Illustrate that embodiments of the present invention, those skilled in the art can be by this explanations by particular specific embodiment below
Content disclosed by book understands other advantages and effect of the present invention easily.
Embodiment 1
A kind of flu phase small peptide formula powder of strengthen immunity, the formula powder are made of the raw material including following parts by weight：It is dense
Contracting PURE WHEY 12%, casein sodium 2%, glucose syrup 40%, mixed vegetable oil 30%, docosahexaenoic acid grease
0.5%, arachidonic acid oil 0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.1%, anhydrous butter oil 0.5%；Multi-vitamins 0.1%, complex mineral
Matter 2.2%, the percentage are the mass percent of raw material gross mass；The mixed vegetable oil includes following components in parts by weight：
Soybean oil 15%, palm oil 10%, sunflower oil 5%, linseed oil 5%, the percentage are that flu phase small peptide formula powder raw material is total
The mass percent of quality；The composite mineral matter includes following components in parts by weight：Calcium carbonate 21-36%, potassium chloride 21-
32%, magnesium sulfate 15-30%, sodium citrate 11-22%, tricalcium phosphate 5-20%, ferrous sulfate 1.5-3.0%, zinc sulfate 0.78-
1.18%, copper sulphate 0.086-0.166%, manganese sulfate 0.01-0.08%, potassium iodide 0.008-0.022%, sodium selenite 0.002-
0.005%, the percentage is the mass percent of composite mineral matter gross mass；The multi-vitamins include following weight parts
Component：L-AA sodium 45-61%, choline chloride 15-31%, inositol 15-30%, niacinamide 1-5%, D-VB5 calcium 0.6-
2%, D-Biotin 0.1-1.0%, cyanocobalamin 0.1-0.8%, thiamine hydrochloride 0.1-0.6%, puridoxine hydrochloride 0.08-0.4%, core
Flavine 0.04-0.2%, folic acid 0.01-0.18%, dl- α-D-α-tocopherol acetates 6.0-7.5%, axerophtholum aceticum 1.5-3%, courage calcification
Alcohol 0.4-1.2%, phytondione 0.2-1.0%, the percentage are the mass percent of multi-vitamins gross mass.
Embodiment 2
A kind of flu phase small peptide formula powder of strengthen immunity, the formula powder are made of the raw material including following parts by weight：It is dense
Contracting PURE WHEY 10%, casein sodium 3%, glucose syrup 50%, mixed vegetable oil 20%, docosahexaenoic acid grease 0.1%
, arachidonic acid oil 0.1%, anhydrous butter oil 0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.5%, multi-vitamins 0.6%, composite mineral matter
2.2%, the percentage is the mass percent of raw material gross mass；The mixed vegetable oil includes following components in parts by weight：Greatly
Soya-bean oil 5%, palm oil 10%, sunflower oil 4%, linseed oil 1%, the percentage are the mass percent of raw material gross mass；Institute
It includes following components in parts by weight to state composite mineral matter：Calcium carbonate 21-36%, potassium chloride 21-32%, magnesium sulfate 15-30%, lemon
Sour sodium 11-22%, tricalcium phosphate 5-20%, ferrous sulfate 1.5-3.0%, zinc sulfate 0.78-1.18%, copper sulphate 0.086-
0.166%, manganese sulfate 0.01-0.08%, potassium iodide 0.008-0.022%, sodium selenite 0.002-0.005%, the percentage are
The mass percent of composite mineral matter gross mass；The multi-vitamins include following components in parts by weight：L-AA sodium
45-61%, choline chloride 15-31%, inositol 15-30%, niacinamide 1-5%, D-VB5 calcium 0.6-2%, D-Biotin 0.1-1.0%,
Cyanocobalamin 0.1-0.8%, thiamine hydrochloride 0.1-0.6%, puridoxine hydrochloride 0.08-0.4%, riboflavin 0.04-0.2%, folic acid
0.01-0.18%, dl- α-D-α-tocopherol acetates 6.0-7.5%, axerophtholum aceticum 1.5-3%, Vitamin D3 0.4-1.2%, plant first
Naphthoquinones 0.2-1.0%, the percentage are the mass percent of multi-vitamins gross mass.
Embodiment 3
A kind of preparation method of the flu phase small peptide formula powder formula powder of strengthen immunity, includes the following steps：It is prepared by base-material（It is wet
Method technique）：（1）It is prepared by water phase：Concentrated whey protein powder, casein sodium are dissolved in 36 DEG C -50 DEG C of purified water, are added
Compound protease is hydrolyzed, pH value 6.0-8.0, hydrolysis temperature be 36-55 DEG C, hydrolysis time 30-120min, be hydrolyzed to by
The peptide or amino acid of 12 amino acid consisting of, molecular weight is below 4000；Heat inactivation compound protease, inactivation temperature 80
DEG C -98 DEG C, time 5min-15min, after being cooled to room temperature, glucose syrup is added, stabilizer high speed shear is uniformly mixed, obtains
Feed liquid A；（2）It is prepared by oil phase：By mixed vegetable oil and Glycerin, mixed triester with caprylic acid capric acid, docosahexaenoic acid grease, arachidonic oil
After mixing, emulsifier 10-32min is added in fat, anhydrous butter oil, and emulsifying temperature is 60-75 DEG C, obtains feed liquid B；（3）
Two-phase mixtures：Feed liquid A is mixed with feed liquid B, composite mineral matter is added, is obtained after shear-mixed, sterilization, spray drying
Material C, the spray drying also include fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40 DEG C；It is dry-mixed（Dry process）：
（4）Multi-vitamins are uniformly mixed with material C to get product.
The step（1）In：Compound protease is flavor protease, alkali protease, neutral proteinase, per 100mL
It is 12100-15000U that enzyme-activity unit is added in PURE WHEY, na caseinate solution；The stabilizer is selected from 1.0%-
2.5% potassium citrate；The step（2）In：The emulsifier is starch Sodium Octenyl Succinate 0.1%-1.5%, citric acid fat
Fatty acid glyceride 0.0%-1.5%, single diglycerol acid aliphatic ester 0.0%-1.5%；The step（3）In：The sterilization conditions are
68 DEG C -70 DEG C of temperature, time 21-40min；Spray drying condition is 160 DEG C -190 DEG C of inlet air temperature, 80 DEG C -95 of temperature of outgoing air
℃；The step（3）In：The spray drying also includes fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40 DEG C；It prepares
The design parameter of obtained product：
| Project | Index（Per 100g） |
| Energy（Kilojoule） | 2164 |
| Protein（g） | 10.4 |
| Carbohydrate（g） | 54.4 |
| Fat（g） | 28.7 |
| Lactose（g） | 0.09 |
| DHA（mg） | 43 |
| ARA（mg） | 43 |
| Glutamine（mg） | 98 |
| Alpha-linolenic acid（mg） | 618 |
| Linoleic acid（mg） | 3.3 |
| Sodium（mg） | 185 |
| Potassium（mg） | 536 |
| Copper（ug） | 257 |
| Magnesium（mg） | 36 |
| Iron（mg） | 4.45 |
| Zinc（mg） | 4.78 |
| Manganese（ug） | 49 |
| Calcium（mg） | 455 |
| Phosphorus（mg） | 321 |
| Iodine（ug） | 70 |
| Chlorine（mg） | 316 |
| Selenium（ug） | 15.3 |
| Vitamin A（Ug retinol equivalents） | 391 |
| Vitamin D（ug） | 7.1 |
| Vitamin E（Mg alpha-tocopherol equivalents） | 10.0 |
| Vitamin K1（ug） | 36 |
| Vitamin B1（ug） | 368 |
| Vitamin B2（ug） | 761 |
| Vitamin B6（ug） | 289 |
| Vitamin B12（ug） | 1.72 |
| Vitamin C（mg） | 79 |
| Niacin（ug） | 2510 |
| Folic acid（ug） | 90 |
| Pantothenic acid（ug） | 2810 |
| Biotin（ug） | 11.9 |
| Choline（mg） | 100 |
| Inositol（mg） | 32 |
| Taurine（mg） | 36 |
| L-cn（mg） | 9.9 |
| Nucleotide（mg） | 40 |
In conclusion 0-6 months infancy stomach are not yet developed completely, gastrointestinal disturbances ability is weak, is wanted to the degree easily absorbed
Higher is sought, higher is required to the comprehensive of nutrition, therefore higher is required to formula powder.A kind of flu of strengthen immunity of the present invention
Phase small peptide formula powder and preparation method thereof contains 0-6 month babies daily required a variety of amino acid, vitamin and trace element
And linoleic acid, alpha-linolenic acid aliphatic acid, DHA, nucleotide etc., and content meets national standard.More can compared to regular convention formula powder
Meet the health demand of flu phase 0-6 month baby, and effectively overcomes various shortcoming in the prior art and have height and produce
Industry utility value.
The above-described embodiments merely illustrate the principles and effects of the present invention, and is not intended to limit the present invention.It is any ripe
The personage for knowing this technology can all carry out modifications and changes to above-described embodiment without violating the spirit and scope of the present invention.Cause
This, institute is complete without departing from the spirit and technical ideas disclosed in the present invention by those of ordinary skill in the art such as
At all equivalent modifications or change, should by the present invention claim be covered.
Claims (8)
1. a kind of flu phase small peptide formula powder of strengthen immunity, it is characterised in that the flu phase small peptide of the strengthen immunity is matched
Square powder includes that following raw material is made：Concentrated whey protein powder 3%-15%, casein sodium 2%-10%, glucose syrup 40%-61% are mixed
Close vegetable oil 10%-36%, docosahexaenoic acid grease 0.1%-0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.1%-0.5%, arachidonic acid
Grease 0.1%-0.5%, anhydrous butter oil 0.1%-0.5%；Multi-vitamins 0.1%-0.6%, composite mineral matter 0.4%-2.2%, it is described
Percentage is the mass percent that flu phase small peptide is formulated powder raw material gross mass；The mixed vegetable oil includes following components：Greatly
Soya-bean oil 1%-15%, palm oil 5%-21%, sunflower oil 4%-15%, linseed oil 0.5%-5.0%, the percentage are mixed plant
The mass percent of oily raw material gross mass.
2. a kind of flu phase small peptide formula powder of strengthen immunity according to claim 1, it is characterised in that complex mineral
Matter is 0-6 month baby's mineral substance premixes, is made of the material mixture of following weight percent：Calcium carbonate 21-36%, chlorination
Potassium 21-32%, magnesium sulfate 15-30%, sodium citrate 11-22%, tricalcium phosphate 5-20%, ferrous sulfate 1.5-3.0%, zinc sulfate
0.78-1.18%, copper sulphate 0.086-0.166%, manganese sulfate 0.01-0.08%, potassium iodide 0.008-0.022%, sodium selenite
0.002-0.005%。
3. a kind of flu phase small peptide formula powder of strengthen immunity according to claim 1, it is characterised in that described compound
Vitamin is 0-6 month baby's vitamin premixs, is made of the material mixture of following weight percent：L-AA sodium
45-61%, choline chloride 15-31%, inositol 15-30%, niacinamide 1-5%, D-VB5 calcium 0.6-2%, D-Biotin 0.1-1.0%,
Cyanocobalamin 0.1-0.8%, thiamine hydrochloride 0.1-0.6%, puridoxine hydrochloride 0.08-0.4%, riboflavin 0.04-0.2%, folic acid
0.01-0.18%, dl- α-D-α-tocopherol acetates 6.0-7.5%, axerophtholum aceticum 1.5-3%, Vitamin D3 0.4-1.2%, plant first
Naphthoquinones 0.2-1.0%.
4. a kind of preparation method of the flu phase small peptide formula powder of strengthen immunity, it is characterised in that include the following steps：
It is prepared by base-material（Wet processing）：（1）It is prepared by water phase：Concentrated whey protein powder, casein sodium are dissolved in 36 DEG C -50 DEG C
Purified water in, be added compound protease be hydrolyzed, pH value 6.0-8.0, hydrolysis temperature be 36-55 DEG C, hydrolysis time 30-
120min is hydrolyzed to by the peptide or amino acid of 12 amino acid consisting of, and molecular weight is below 4000；Heat inactivation compound protein
Enzyme, inactivation temperature is 80 DEG C -98 DEG C, time 5min-15min, after being cooled to room temperature, glucose syrup is added, stabilizer high speed is cut
It cuts uniformly mixed, obtains feed liquid A；（2）It is prepared by oil phase：By mixed vegetable oil and Glycerin, mixed triester with caprylic acid capric acid, docosahexaenoic acid oil
After mixing, emulsifier 10-32min, emulsifying temperature 60-75 is added in fat, arachidonic acid oil, anhydrous butter oil
DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, composite mineral matter is added, by shear-mixed, kills
Material C is obtained after bacterium, spray drying, the spray drying also includes fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40
℃；
It is dry-mixed（Dry process）：（4）Multi-vitamins are uniformly mixed with material C to get product；
Or include the following steps：
It is prepared by base-material（Wet processing）：（1）It is prepared by water phase：Concentrated whey protein powder, casein sodium are dissolved in 36 DEG C -50 DEG C
Purified water in, be added compound protease be hydrolyzed, pH value 6.0-8.0, hydrolysis temperature be 36-55 DEG C, hydrolysis time 30-
120min is hydrolyzed to by the peptide or amino acid of 12 amino acid consisting of, and molecular weight is below 4000；Heat inactivation compound protein
Enzyme, inactivation temperature is 80 DEG C -98 DEG C, time 5min-15min, after being cooled to room temperature, glucose syrup is added, stabilizer high speed is cut
It cuts uniformly mixed, obtains feed liquid A；（2）It is prepared by oil phase：By mixed vegetable oil and Glycerin, mixed triester with caprylic acid capric acid, docosahexaenoic acid oil
After mixing, emulsifier 10-32min, emulsifying temperature 60-75 is added in fat, arachidonic acid oil, anhydrous butter oil
DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, is obtained after shear-mixed, sterilization, spray drying
Material C, the spray drying also include fluidized bed drying, and fluidized bed drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, composite mineral matter are uniformly mixed with material C to get product.
5. the preparation method of the flu phase small peptide formula powder of strengthen immunity according to claim 4, it is characterised in that institute
State step（1）In compound protease include flavor protease, alkali protease, neutral proteinase, additive amount is every
It is 12100-15000U that enzyme-activity unit is added in 100mL PURE WHEYs, na caseinate solution；The stabilizer is selected from
The potassium citrate of 1.0%-2.5%, the percentage are the mass percent that flu phase small peptide is formulated powder raw material gross mass.
6. the preparation method of the flu phase small peptide formula powder of strengthen immunity according to claim 4, it is characterised in that institute
State step（2）In emulsifier be starch Sodium Octenyl Succinate 0.1%-1.5%, citric acid fatty glyceride 0.0%-1.5%,
Single diglycerol acid aliphatic ester 0.0%-1.5%, the percentage are the quality percentage that flu phase small peptide is formulated powder raw material gross mass
Than.
7. a kind of preparation method of the flu phase small peptide formula powder of strengthen immunity according to claim 4, feature exist
In：The step（3）In sterilization conditions be 68 DEG C -70 DEG C of temperature, time 21-40min；Spray drying condition is inlet air temperature
160 DEG C -190 DEG C, 80 DEG C -95 DEG C of temperature of outgoing air.
8. a kind of preparation method of the flu phase small peptide formula powder of strengthen immunity according to claim 4, feature exist
In：The step（3）In spray drying be selected from fluidized bed drying, fluidized bed drying temperature be 30 DEG C -40 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810622097.8A CN108741103A (en) | 2018-06-15 | 2018-06-15 | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810622097.8A CN108741103A (en) | 2018-06-15 | 2018-06-15 | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108741103A true CN108741103A (en) | 2018-11-06 |
Family
ID=63978305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810622097.8A Pending CN108741103A (en) | 2018-06-15 | 2018-06-15 | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108741103A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113925170A (en) * | 2021-09-26 | 2022-01-14 | 南昌大学 | Bean-based formula powder with anti-fatigue and immunity-improving functions and preparation method thereof |
| CN116138438A (en) * | 2023-04-19 | 2023-05-23 | 益欣汇盛科技(北京)有限公司 | Oil-in-water submicron emulsion system and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102613300A (en) * | 2012-04-24 | 2012-08-01 | 澳优乳业（中国）有限公司 | Infant formula milk powder for preventing diarrhea and preparation method thereof |
| CN108142562A (en) * | 2018-03-06 | 2018-06-12 | 青岛金大洋乳业有限公司 | A kind of formula powder and preparation method of the oral immunological tolerance of induction moderately hydrolyzed |
-
2018
- 2018-06-15 CN CN201810622097.8A patent/CN108741103A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102613300A (en) * | 2012-04-24 | 2012-08-01 | 澳优乳业（中国）有限公司 | Infant formula milk powder for preventing diarrhea and preparation method thereof |
| CN108142562A (en) * | 2018-03-06 | 2018-06-12 | 青岛金大洋乳业有限公司 | A kind of formula powder and preparation method of the oral immunological tolerance of induction moderately hydrolyzed |
Non-Patent Citations (1)
| Title |
|---|
| 崔玉涛: "《崔玉涛图解家庭育儿：最新升级版.3》", 31 January 2017, 人民东方出版传媒有限公司 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113925170A (en) * | 2021-09-26 | 2022-01-14 | 南昌大学 | Bean-based formula powder with anti-fatigue and immunity-improving functions and preparation method thereof |
| CN116138438A (en) * | 2023-04-19 | 2023-05-23 | 益欣汇盛科技(北京)有限公司 | Oil-in-water submicron emulsion system and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108029768A (en) | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof | |
| CN103070241B (en) | Infant-formula goat milk powder of pure goat milk protein and preparation method thereof | |
| CN106343029A (en) | Infant formula for improving intestinal absorption and comfort and preparing method thereof | |
| CN108522655A (en) | The baby milk and preparation method of micro functional active components in a kind of across-the-board regulation formula | |
| CN103053694A (en) | Infant goat milk powder simulating components of breast milk and preparation method thereof | |
| CN103053692A (en) | Lactoferrin and nucleotide-added baby formula goat milk powder and preparation method thereof | |
| CA2821725A1 (en) | Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid | |
| CN109077123A (en) | A kind of infant formula goat milk powder produced using concentrating and desalinating sheep whey liquid | |
| CN104920618A (en) | Formula goat milk powder for pregnant and lying-in woman | |
| CN105994680A (en) | Infant formula goat milk powder and preparation method thereof | |
| CN108013143A (en) | One kind strengthens the formula milk of 12 ~ 36 months infant's gastrointestinal functions | |
| CN103070242A (en) | Formula goat milk powder for pregnant women and preparation method of formula goat milk powder | |
| US20240108050A1 (en) | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid | |
| CN111067104A (en) | Composite probiotic infant formula milk powder and preparation method thereof | |
| CN108741103A (en) | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof | |
| CN111587923A (en) | An infant formula containing sialic acid and its preparation method | |
| CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
| CN117481199A (en) | Premature/low birth weight infant food for promoting growth and development, and preparation method and application thereof | |
| CN107467193A (en) | Full nutrition special medicine purposes formula food of a kind of pulvis based on goat milk and preparation method thereof | |
| KR101356926B1 (en) | Goat milk infant formula comprising humanized protein composition for improved digestibility | |
| CN112868803A (en) | Formula milk powder for improving breast milk nutrition and preparation method thereof | |
| CN111345352A (en) | Contains vitamin K2Children's formula milk powder of yak milk mixed with sialic acid and preparation method | |
| EP2956015B1 (en) | Method for restoring and/or maintaining a positive net protein balance in a child | |
| CA2475105C (en) | Human milk supplement | |
| CN108902956A (en) | A kind of amino acid formula powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181106 |